We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9901:HKEXNew Oriental Education & Technology Group, Inc. Analysis

Data as of 2026-07-18 - not real-time

HK$38.94

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

New Oriental is trading well above its discounted cash‑flow estimate, with the market price sitting far beyond the fair‑value level, indicating a sizable premium. The 20‑day and 50‑day simple moving averages sit below the current price, while the 200‑day SMA remains higher, underscoring a bearish longer‑term bias. Momentum signals are mixed: the MACD histogram is positive and the RSI hovers in the neutral‑to‑overbought zone, but the overall trend direction is flagged as bearish and volume is on a downtrend. These technical cues suggest limited upside in the near term, with the price approaching a nearby resistance zone.
On the fundamentals side, the company delivers solid revenue growth and attractive margins, supported by a healthy cash pile and low leverage. The dividend yield of over 2% is backed by a modest payout ratio, making the payout appear sustainable. However, the sector faces heightened regulatory scrutiny in China, and the stock’s beta is low, indicating limited market‑wide volatility but the recent 30‑day volatility remains elevated. Investors should weigh the attractive cash flow and dividend against the overvaluation and regulatory headwinds before making a decision.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish longer‑term trend despite short‑term MACD bullishness
  • Current price above support but below fair value
  • Decreasing volume indicating waning buying pressure

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Steady revenue growth and solid operating margins
  • Sustainable dividend yield with low payout ratio
  • Regulatory environment in China remains uncertain

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Significant overvaluation relative to DCF fair value
  • High regulatory risk for private education providers
  • Potential for earnings compression if policy tightening continues

Key Metrics & Analysis

Financial Health

Revenue Growth19.80%
Profit Margin7.82%
P/E Ratio18.4
ROE10.84%
ROA4.85%
Debt/Equity18.27
P/B Ratio1.9
Op. Cash FlowHK$907.5M
Free Cash FlowHK$617.3M

Technical Analysis

TrendBearish
RSI58.5
SupportHK$34.26
ResistanceHK$40.08
MA 20HK$37.05
MA 50HK$37.88
MA 200HK$42.13
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair ValueHK$13.85
Target PriceHK$54.99
Upside/Downside41.22%
GradeOvervalued
TypeBlend
Dividend Yield2.42%

Risk Assessment

Beta0.29
Volatility29.34%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.